Bank of New York Mellon’s LB Pharmaceuticals LBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LBRX
LF
YIH
AA
QC
Bank of New York Mellon's LBRX Position: Q2 2026 in Review
Bank of New York Mellon increased its LB Pharmaceuticals (LBRX) stake by 21% in Q2 2026, buying an estimated $280K and bringing the position to 54,979 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3015.
Bank of New York Mellon first reported a position in LBRX in Q4 2025 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.
- Bank of New York Mellon held 54,979 shares of LB Pharmaceuticals worth $1.78M as of Q2 2026.
- Bank of New York Mellon bought 9,522 LB Pharmaceuticals shares in Q2 2026, an estimated $280K.
- LB Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3015 holding.
- Bank of New York Mellon first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 29 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.